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ABSTRACT 
 
Human longevity is a complex trait, and to disentangle its basis has a great theoretical and practical 
consequence for biomedicine. The genetics of human longevity is still poorly understood, despite a number 
of investigations that used different strategies and protocols. Here we argue that such rather disappointing 
harvest is largely due to the extraordinary complexity of the longevity phenotype in humans. The capability 
to reach the extreme decades of human lifespan appears to be the result of an intriguing mixture of  gene-
environment interactions. Accordingly, the genetics of human longevity is here described as a highly 
context-dependent phenomenon, within a new integrated, ecological and evolutionary perspective,  and  is  
presented  as a dynamic process, both historically and individually. The available literature has been 
scrutinized within this perspective, paying particular attention to factors (sex, individual biography, family, 
population ancestry, social structure, economic status and education, among others) that have been 
relatively neglected. The strength and limitations of the most powerful and used tools, such as GWAS and 
whole-genome sequencing, have been discussed, focusing on prominently emerged genes and regions, 
such as APOE, FOXO3, IL-6, IGF-1, chromosome 9p21, 5q33.3 and somatic mutations among others. The 
major results of this approach suggest that: i) the genetics of longevity is highly population-specific; ii) 
small-effect alleles, pleiotropy and the "complex allele timing" likely play a major role; iii) genetic risk 
factors are age-specific and need to be integrated in the light of the geroscience perspective; iv) a close 
relationship between genetics of longevity and genetics of age-related diseases (especially cardiovascular 
diseases) do exist. Finally, the urgent need of a global approach to the largely unexplored interactions 
between the three genetics of human body, i.e. nuclear, mitochondrial and microbiomes, is stressed. We 
surmise that the comprehensive approach here presented will help in increasing the above-mentioned 
harvest. 
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1. Introduction 
 
It is recognized that long-lived mammalian species (e.g. naked mole rat, blind mole rat and elephant, 
among others) evolved unique traits, highly related to their specific environmental niche, to attain 
longevity 1. Many studies have been made on animals models but in humans the capability to reach the 
extreme decades of lifespan appears to be the result of an intriguing mixture of gene-environment 
interactions and in this review despite the interesting findings in animals models we will focus only on the 
genetics of longevity in humans.  Homo sapiens is a long-lived mammal and likely evolved peculiar longevity 
mechanisms. Modern humans are characterized by a higher level of complexity due to their biological and 
cultural capability of adapting to all areas of the planet and changing their environments, by developing an 
extraordinary variety of cultural adaptive strategies. This specific characteristic had and still has a strong 
impact on the molecular and cellular mechanisms involved in aging and longevity. Accordingly, the genetics 
of human longevity is here described as a highly context-dependent phenomenon, within a new integrated, 
ecological and evolutionary perspective, and it is presented as a dynamic process, both historically and 
individually. During the entire lifespan new gene-environment interactions emerge as a consequence of the 
continuous “remodeling” process that the body set up to adapt to the deteriorative changes occurring over 
time 2, which on the other hand occur concomitantly with the changes of the environment. In this complex 
scenario, many factors (population genetics, demography, sex, family, immunobiography, 
physical/geographical and cultural/anthropological environment, social networks, socio-economic status 
and education) need to be carefully considered and integrated in order to understand the contribution of 
genetics in attaining healthy aging and extreme longevity. The high throughput technologies used for the 
analysis of genetic data - as well as the data on the most relevant genes - highlighted the close relationship 
between the genetics of longevity and population-specific dynamics, as well as the importance of small 
effect alleles, pleiotropy and the complex “allele timing”, supporting the assumption that genetic factors 
involved in human longevity need to be defined according to a large range of biological and non-biological 
variables. Moreover, the genetic of longevity is linked with many age-related diseases (especially 
cardiovascular diseases - CVD), coherently with the new geroscience perspective 3. Geroscience suggests 
that the mechanisms underpinning aging are deeply involved in the pathogenesis of age-related non 
communicable chronic diseases, and has identified seven common pillars (adaptation to stress, epigenetics, 
inflammation, macromolecular damage, metabolism, proteostasis and stem cells and regeneration). 
Geroscience emphasizes that aging promotes diseases, being the most important risk factor, and that in 
turn diseases and/or their treatments accelerate the aging process 4, and at the same time represents the 
conceptual framework to understand the role of genetic (protective) factors which allow few individuals to 
reach the extreme limit of human life. This review highlights also the plastic and deep interactions between 
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autosomal DNA, mtDNA and microbiomes which, together with somatic mutations occurring lifelong, 
continuously create new and unique interactions among these genomes in each individual. 
2. The complexity of human longevity  
2.1. The definition of longevity 
The definition of “longevity” is highly debated and the lack of a universally recognized definition increases 
the possibility of misinterpretation and biases in comparing different studies aimed at establishing the 
genetic contribution on this trait. Moreover, in the literature the terms "lifespan", "oldest old", "aging" and 
"longevity" are often use interchangeably. Longevity can be defined as the result of mortality selection 
overall age-classes, where cumulative mortality is historically and context-dependent. The birth cohort and 
the percentile of survival are thus two parameters crucial for the definition of longevity rather than the 
chronological age itself. Demographic studies showed that there are differences between members of a 
birth cohort who live 90, 100, 105 and 110+ years, and thus they may reflect important genetic differences 
5. The study of Sebastiani and colleagues5 showed that the siblings’ relative probability to survive to older 
ages increase with age, suggesting that the genetic influence upon survival continuously increases reaching 
the highest levels around the extreme limits of lifespan. 
This observation leads to the important consideration that the power to detect genetic association with 
longevity is greater for centenarians versus nonagenarians subjects of the same birth cohort 6. Thus, a 
recent paper - in order to avoid problems of inconsistency in the definition - suggests that longevity has to 
be defined according to percentile survival based upon the reference birth cohort for each population, 
indicating that the environmental context play a critical role on this specific phenotype. One percentile 
survival is the threshold suggested to maximize the probability to identify genetic association 7. Moreover 
familial longevity is also a criteria used in the study of the genetics of human longevity: the GEHA (Genetics 
of Healthy Ageing) Study includes nonagenarian sibling pairs to select families enriched for genetic 
influences on longevity 8.  
 
2.1.1. Heritability and missing heritability in longevity  
The definition of longevity opens new consideration on the estimation of heritability that is often 
considered around 25 ± 5% on the basis of twin studies that, however, includes a limited (or null) number 
of 90+ couples . In fact these studies likely reflect the heritability for age at death in modern society rather 
than the variation of the trait (longevity) explained by genetic determinants.  
An example of the problems and bias inherent in the definition of longevity in human is exemplified by  the 
study from Kaplanis et al. 9 where the authors estimated heritability of longevity around 16%. The results 
suggested a robust additive genetic component, a small impact of dominance, and no detectable epistasis 
CIRCRES/2017/312562/R1 
5 
 
on longevity heritability. The study is interesting for the digital approach to genealogical data and for the 
high number of individuals considered (around 3 million from online dataset of genealogy profiles of 
worldwide population). However the estimation of heritability is built around a very high range of birth 
cohorts (1600-1910), from different populations, and no long-living individuals are present (individuals > 
100 years old were filtered out) 9. These contrasting and biased results take us to the emerging concept of 
missing heritability in the study of complex traits, including longevity. To date genomics identified only a 
small proportion of the expected heritability of longevity. In a recent study it was proposed that the missing 
heritability is strictly related  to the methods used for the heritability calculation itself 10. In particular the 
evaluation of heritability is based on an additive model for complex traits that does not consider other 
inheritance patterns, such as epistasis among others 10. In literature example of epistatic interactions  in 
longevity exists 11–13. Tan and colleagues 14 analyzing centenarians identified a significant association 
between the interaction REN gene allele/mitochondrial haplotype H and longevity while the two gene 
analysed separately showed no significant association. 
Moreover heritability may be biased by unaccounted environmental effects whose relation with the 
genetics of human longevity will be extensively described in section 3. Variation between phenotypes in a 
population arises because of the average differences between the genotypes or because each genotype 
exhibits phenotypic variance because of environmental variation. A detailed analysis of variants affecting 
behaviour and mating will be relevant in order to understand another potential bias in heritability, i.e. the 
covariance between genes and culture. The polygenic nature of longevity promoted the idea that larger 
cohorts are needed to identify the variants, but this approach inevitably causes an increase of the 
heterogeneity of the cohorts and of environmental confounding factors at the expense of the biology 
underpinning the trait. Lastly some authors suggested that part of the missing heritability should be 
searched in non-DNA factors that may be transmitted between generations 15 as important data that 
connect epigenetic inheritance and longevity from non-human models are emerging 16–19. Interestingly 
analysis and integration of DNA methylation data and RNAseq will be useful tool 20, but a big effort is still 
needed to collect data on the same pool of samples 21. 
 
2.1.2. The phenotype of human extreme longevity 
From the previously mentioned studies emerged that the genetic contribution to longevity increases with 
age, thus centenarians (100 years of age), semi-super centenarians (105 years of age and more) and super 
centenarians (110 years of age and more) are the more informative subjects for investigating the genetics 
of human longevity. One of the emerging problems in the genetic studies is the characterization of the 
phenotype to include in the analysis. "Phenomics" is a term introduced by the evolutionary biologist 
Michael Soulè, and it includes all the possible way to characterize populations and individuals 22. 
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Centenarians and semi-supercentenarians have been deeply characterized and the main results are briefly 
summarized (and reported in Figure 1): 
1) Biochemical parameters: centenarians have a phenotype similar to that of calorie-restricted individuals 
and they have a good metabolic profile, characterized by preserved glucose tolerance and insulin 
sensitivity, low serum level of IGF-I and IGF-II 23,24. 
2) Prevalence of age-related diseases: centenarians markedly compress the period of their lives spent with 
disability 25 and they avoided or largely postponed all major age-related disease 4,26–30. Consistent with the 
compression of morbidity scenario, people surviving beyond age 105 years are also phenotypically much 
more similar to one another than younger individuals dying in their 1980s and 1990s 5. 
3) Epigenetics: according to the epigenetic clock, centenarians showed a decreased in DNA-methylation 
ages 31 indicating that they are biologically younger than their chronological age.  
4) Metabolomics: an analysis conducted on plasma and urine of Italian centenarians and their offspring has 
identified the first metabolomic signature of healthy aging. Specific glycerophospholipids and sphingolipids 
and a decreased in tryptophan concentration have been described in centenarians from North Italy 32. This 
centenarian metabolomic signature showed peculiar changes in pro- and anti-inflammatory compounds 
and detoxification through specific modulation of the arachidonic acid metabolic cascade and enhanced 
cytochrome P450 (CYP) enzyme activity.  
5) Biology of circadian rhythms: this is an emerging aspect linked to familial longevity, likely influenced by 
genetic background and by social and environmental dynamics33. Circadian rhythms, including central 
(located in the suprachiasmatic nucleus) and peripheral clocks, deteriorate during aging 34 but they appear 
to be well preserved in centenarians, including sleep39, even if the data are still scarce and often related to 
a limited number of subjects 23. Studies on offspring of long lived subjects showed preserved rhythmicity of 
serum non-HDL-C concentration when compared to general population, and centenarians present good 
sleep quality. Genetic of circadian rhythms is highly population-specific in humans 35,36. Study in mice 
showed that SIRT1 is the gene at the intersection between longevity and circadian rhythms and increasing 
SIRT1 levels in the brain of genetically altered mice seems to reduce the age-related decay of circadian 
functions37.  
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Figure 1. Major characteristics of the centenarians’ phenotype. This figure is inspired by Franceschi et al., 
Annu. Rev. Nutrition, 2018 and is based on data collected on Italian centenarians. 
 
2.2. The definition of controls in the genetics of longevity  
If the definition of longevity is cumbersome the definition of controls in the study of the genetic of 
longevity is even more complex, and has constituted a major challenging issue. Noteworthy, the studies can 
be divided into two main groups: 1) studies including younger healthy controls from the same family or 
from the general population; 2) studies including  patients affected by age-related diseases assuming that 
such  diseases constitute a condition of accelerated aging, as recently argued 4. In addition, a new definition 
of controls is emerging thanks to the new era of molecular biomarkers of aging that introduce the concept 
of “biological age” (described in the section "perspectives"). 
 
2.2.1 Controls as healthy individuals younger than cases (e.g. centenarians) 
For the study of sporadic longevity the choice of controls constituted a challenging and debated issue. Once 
the threshold for  longevity is defined, many studies randomly selected unrelated subjects  from the 
general population as controls, assuming that the prevalence of possible centenarians in the control group 
is small and negligible owing to the rarity of the trait 38. A second strategy is to select as a group of control 
individuals who did not survive over the average life expectancy of their demographic cohort, thus reducing 
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in the control group the possible enrichment of longevity variants and increasing the power of a study. Both 
strategies have pros and cons, as illustrated  in a recent paper 7 , but in both cases the results may be 
biased by the different birth cohorts of centenarians and controls.  
2.2.2. Controls as individuals affected by age-related diseases 
 
Recently, the idea emerged that patients affected by age-related diseases could be an effective control 
group for the study of the genetics of longevity39–41, for two main reasons : 1) long living subjects such as 
centenarians and patients affected by age-related diseases constitute "extreme phenotypes", and the 
comparison between most divergent phenotypes can increase the probability to identify disease-specific  
genetic protective factors linked to longevity; 2) a group of individuals with a specific age-related disease 
help to disentangle the genetic heterogeneity of the control group that inevitably is composed of 
individuals most of whom will likely develop one or more  age-related diseases that eventually reduce their 
chances to reach longevity (Figure 2). The concept that aging and chronic pathologies share common 
mechanisms and constitute a continuum where centenarians and patients affected by age-related diseases 
represent the opposite side of the spectrum is at the basis of the inclusion of age-related patients in studies 
on the genetics of human longevity 41. 
As far as we know, the first study within this framework was performed in 2013 by Garagnani and 
colleagues 39 on the most important genetic risk factor for type 2 diabetes (T2D), i.e. the TCF7L2 rs7903146 
genetic variant. The authors investigated the TCF7L2 risk allele distribution in a phenotypic continuum 
spanning from diabetic patients with micro- and macro-vascular complications (i.e. the most severe age-
related phenotype) to centenarians (that never had T2D) on a total of 1,349 individuals. The frequency of 
the risk allele genotypes (TT) and the OR value increased gradually according to the decreasing of 
health/longevity and the increasing of T2D severity. 
A second study 40 applied a cross-diseases analysis for the study of longevity. The authors calculated for 
each SNP an "age-related disease score" (weight) by evaluating a high number of different genome wide 
analysis on age-related diseases. The score was able to distinguish between disease-specific SNPs and 
"aging SNPs" that are involved in multiple diseases. Then, these weights were used for the p-values 
calculated from longevity association analysis in order to integrate in the longevity assessment the age-
related disease genetic knowledge. With this method they identified eight genes involved in extreme 
longevity likely protecting against specific age-related diseases such as APOE/TOMM40 (associated with 
Alzheimer’s disease), CDKN2B/ANRIL (CVDCVD), ABO (tags the O blood group),  SH2B3/ATXN2 (neurological 
disease), HLA, LPA, FADS1 and KCNT2. The latter study we consider compared 53 healthy centenarians and 
45 patients with Alzheimer's disease (AD) both of Ashkenazi Jewish ancestry 42. The authors found that a 
burden for rare protein truncating mutations is absent in centenarians while they characterized AD 
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patients. This extreme phenotype approach is twice powerful since it provides information both on risk and 
protective factors for major age-related diseases43–45. 
Figure 2 summarized the genetic heterogeneity of the groups considered for the genetic study of human 
longevity.  
 
Figure 2. Definition of longevity and control groups for the study of genetics of human longevity. Genetic heterogeneity 
of the groups is reported. Lengths of the arrows is proportional to the level of genetic heterogeneity of each group.  
3. The genetic of longevity: insight from ecology    
It is well established that longevity is influenced by a complex relation between environment, genetics and 
stochastic factors. Such complexity is appropriately taken into account by ecological models  rarely 
considered in the study of human longevity 46. The evolutionary concept of "niche construction" 47–50 
suggests that individuals’ genetics interacts with the external world and the environment that each species 
creates. For humans, niche construction is influenced by socially transmitted behaviour that constitutes in 
fact a triple inheritance system including 1) genetic, 2) culture and 3) ecological dimension. Accordingly, we 
will assume the relationship with the environment as the fil rouge of the analysis of the genetics of 
longevity presented in this section. To understand this complex ecosystem we assume that the interactions 
with genetics in each individual may vary according to her/his specific characteristics. Thus we start first 
from the description of the biological identity of each individual that is determined by innate characteristics 
(such as sex and rare variants) and by features acquired during lifetime (such as somatic mutations and 
immunological stimuli that constitutes immunobiography). Then we describe three dimensions capable of 
encompassing the different timescale of interactions between genes, culture and ecology as reported in 
Figure 3 (ecological-space): 
1) the genetics of families (assortative mating or indirect effect of parents' genotypes);  
2) the genetic of human populations (population genetics and population specific gene-environment (GxE) 
interactions);  
3) the genetic of longevity and socio-economic factors. 
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Figure 3. The ecological space is responsible for the peculiar gene-environment interactions of each individual. 
Individuals, families, and communities (such as school, work, religion, among others) are represented by  black dots, 
green and red circles, respectively, while the blue circles represent populations in term of genetic ancestry. Cultural 
processes are represented as horizontal orange shadows. Migration and mobility increase the possibility to identify 
different human populations in the same communities, which can share, at least in part, the same ecological space. 
 
 
3.1. The genetics of longevity: individual variability 
3.1.1 Biological biography: the example of immunobiography 
The ecological perspective indicates that longevity is the result of dynamic interactions between genetics 
and environment. In particular gene-environment interaction in centenarians are peculiar of each individual 
because the combination of stimuli experienced during life interacting with the unique genetic background 
results in a unique signature. This concept has been conceptualized from an immunological perspective and 
dubbed “immunological biography” 51,52. Owing to its memory and plasticity, the immune system (IS), 
including both the innate and the adaptive ones, is capable of recording all the immunological experiences 
and stimuli it was exposed to. Immune responses are influenced and shaped by, at least, two dimensions: i) 
space, composed by the relations between human being and their specific peculiar environment, according 
to the geography and history of the population to which she/he belongs to (pathogens, nutrition, climate, 
lifestyle, among others); ii) time, since each individual is the result of time-dependent adaptive processes 
(such as immunosenescence and inflammaging).  
These considerations can be applied to other organs and systems of the body (such as the brain, the 
endocrine systems, the gut microbota among others) which also have the capability to make records of 
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previous lifelong stimuli, contributing to create the individual biological biography which impacts on the 
aging process and trajectory, starting from the first stage of life.  
3.1.2. Individual genetic identity: germline (rare variants) and acquired (somatic) mutations  
The genetic identity of each individual is a dynamic process because each person has a unique genetic 
composition with a peculiar combination of common and rare or even private de novo variants (germline 
variations) but at the same time accumulation of somatic mutations is observed during aging. The 
combinations of these genetic variants constitute the individual genetic identity that continuously evolves 
with age. 
Genetic variants can be categorized according to their frequency in the general population an from this 
point of view each individual carries a number of private variants not shared by other individuals. The study 
of rare variants in aging and longevity is challenging since longevity is by definition a rare phenotype. To 
this regard  two main approaches can be envisaged: i) to study the effect of these variants combining large-
scale DNA sequencing and their functional testing in targeted molecular experiments53,54;ii) to study 
population isolates. This approach has been successful in detecting rare variants associated with complex 
phenotypes 55 as these populations are characterized by genetic homogeneity and rare variants may have 
drifted up in frequency, in fact the effect of random genetic drift on increasing allele frequencies is higher 
for rare compared with common variants 56,57. 
Another element contributing to genetic identity is somatic mosaicism that occurs lifelong in all human 
tissues: from the fertilization until death individuals accumulate somatic mutations. This accumulation is 
the result of exposure to external agents  (such as UV and pollutants) but also a consequence of errors in 
DNA duplication process, DNA double-strand breaks, inefficient DNA repair, unbalanced chromosomal 
segregation 58,59. The accumulation of unrepaired DNA damages,  the decline in  DNA repair efficiency and 
replicative senescence are well established characteristics of aging  60–63, as confirmed in a study on Italian 
centenarians64. Somatic mutations in autosomal DNA and in particular clonal hematopoiesis are an 
emerging link between longevity and cardiovascular diseases and a detail description is reported in section 
5.3. 
Somatic mosaicism of mitochondrial DNA, referred as "heteroplasmy", was reported in many aging studies 
showing an accumulation of mtDNA mutations during aging in healthy individuals. Moreover heteroplasmy 
inheritance was confirmed in a study that applied an ultra-deep DNA sequencing approach, capable of 
detecting very low frequency alleles, on female centenarians and their  offspring 65. The analysis showed a 
heteroplasmy profile (in term of total heteroplasmies levels and loci) peculiar for each individual (private 
component) but also the presence of heteroplasmies shared between mother and daughter within each 
family, thus indicating a familial specific contribution of low level heteroplasmies to the genetics of human 
longevity .  
 
CIRCRES/2017/312562/R1 
12 
 
3.1.3. The genetics of human longevity and sexual dimorphism  
It is well known that human longevity - with some exception - is strongly correlated with sex, and that 
females generally live longer than male, likely because of the combination of biological factors (anatomy, 
reproductive functions, sex hormones, expression of genes on the X or Y chromosome) and social factors 
related to behaviour, population and peculiar life experiences 66–68 as showed in Figure 4. 
 
 
Figure 4. Female/male distribution in the Italian population and centenarians. A) The survivorship in Italy per 100000 
individuals at different ages is reported. Females and males are indicated in red and blue, respectively. The triangle on 
the left indicates the influence of genetics on the longevity trait. B) The upper heatmap shows that the Italian 
female/male centenarians’ ratio increases from North to South (Passarino et al. 2002). The lower map shows the Y 
chromosome’s genetic variability in Italy (Boattini et al. 2015). Black squares represent positive values of the spatial 
principal component analysis (sPCA), while white squares represent the negative ones; the size of the squares is 
proportional to the absolute value of sPCA scores. On the whole, autosomic and uniparental genetic variability, cultural 
and social structure and sex present a well defined distribution across Italian population 
 
Gender influences also the inheritance of exceptional longevity 69. The analysis of parental age of a cohort 
of Ashkenazi Jews with exceptional longevity revealed that in males both maternal and paternal inheritance 
are likely contributors to exceptional longevity, whereas among females maternal inheritance appears to 
be more influential 69.  Evolutionary studies provide clues for the interpretation of these sex specific 
influences 70.   
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Sex hormones are the first example and in particular the removal of testosterone at young ages has been 
demonstrated to increase lifespan in mammals 71 and in humans, as supported by the Korean population of 
eunuchs 72. In male, there is a trade-off between immune investment and traits that improve competitive 
success, which has driven genetic variation in genes involved in testosterone levels during human 
evolution. Since immune responses are energy demanding processes, testosterone plays a major role in 
male to increase muscle growth but at the same time reduces immune responses (testosterone is 
considered an immunosuppressant) 73,74. 
A second example is linked to cultural factors that could also contribute to the observed sex differences.. 
The "grandmother hypothesis", spread around 1980 when researchers found that among Hadza hunter-
gatherers (Tanzania) mothers faced a trade-off between foraging for food for themselves and caring for 
new babies. This cultural process - observed only in humans - may have shaped genetic variants conferring 
sex-specific advantage for survival after menopause because women who remained healthy beyond their 
fertile years may have enhanced their reproductive success by providing care for their grandchildren 75. 
Third, mitochondrial genome is a major player for the differences in longevity between sexes. This is 
because mtDNA is maternally inherited, and this genome can only make a direct and adaptive response to 
selection through females, as experimentally demonstrated in Drosophila by cutting edge studies 76,77. This 
means that mutations with a negative effect in males can accumulate in the population if they are neutral 
or beneficial for females (phenomenon called Mother Curse). The study of Camus and colleagues 77 
suggested that mitochondrial genome is a hotspot for mutations that affect sex-specific patterns of aging, 
and this phenomenon contributes to sexual dimorphism in aging 78. The interaction between nuclear DNA 
and mitochondrial genome (hereafter mitonuclear interactions) plays a major role in explaining variance in 
penetrance and expression of mitochondrial diseases with different trend in different sexes 79. The 
accumulation of mtDNA mutations, which impact on the OXPHOS functionality, constitutes an intense 
selective pressure on the nuclear genome for counter-adaptations that restore the compromised function. 
Data in Drosophila melanogaster suggested that this process is strongly influenced by sex. Experiments on 
isonuclear fly lines whereby distinct mitochondrial haplotypes have been placed into a standardized foreign 
nuclear background indicate that a disruption of the coevolved mitonuclear genotype lead to males, but 
not females, sterility 76,80.  
 
More in general, the evolutionary dynamics maximizes the number of offspring leading to different fitness 
in males and females (Figure 5). Females can have a limited number of offspring for physiological reasons 
(number of gametes and energetic costs of each pregnancy), while males tend to be limited by the number 
of matings. This leads to a different selection dynamics in female that it is not observed in male, as 
supported by a recent study that showed an accumulation of deleterious mutations in genes exclusively 
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expressed in male 81 (Figure 5). Sex-limited selection can moderate the elimination of deleterious mutation 
from the general population and leaving deleterious mutations expressed specifically in men.  
 
 
 
Figure 5. Evolutionary dynamics maximizes fitness according to reproductive effectiveness. Females can have a 
limited number of offspring for physiological reasons (number of gametes and energetic cost of pregnancy), while 
males are limited by the number of matings (down part of the figure). Evolution strongly favoured female fitness since 
the number of reproductive active females is the limiting factor determining the newborn number for each generation. 
This difference leads inevitably to different sex-specific dynamics of selective pressures on both mitochondrial and 
nuclear genomes that are strong for female than for males .   
 
The dimorphism in longevity has been only recently introduced in the study of the genetics of human 
longevity. In the GEHA study, a linkage analysis was performed in 90+ male (N pairs=263) and female (N 
pairs 1145) sibpairs and three loci that linked to longevity in a sex-specific manner were identified: 8p11.21-
q13.1 (men), 15q12-q14 (women), and 19q13.33-q13.41 (women) 8. A very recent GWAS study 82 
investigated the association with longevity separately in men and women in a cohort of more than 2200 
Chinese centenarians. The authors did not find any locus associated with longevity above the formal 10-8 
GWAS threshold, but a series of interesting sex-specific longevity alleles were identified. In the study the 
polygenic risk score was successfully applied to investigate associations' signals below the GWAS 
significance threshold. The score results indicate that different pathways contribute to longevity in men 
and women. In particular, paths involved in inflammation and immunity emerged as male-specific while 
those involved in PGC-1a function and tryptophan metabolism emerged as female-specific. It is worth 
noting that the GWAS approach likely limited the sex-specific analysis of longevity due to the obvious 
reduction of the dimension of the cohorts when splitted into females and males.  
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3.2. Familial ecology and the genetic of longevity 
“Longevity runs in families” is a statement that introduces the vast majority of papers about the genetics of 
human longevity and families constitute a niche in ecological term. One of the first evidence came from 
studies in the Sardinian population (Italy), based on a geographical-genealogical approach. These studies 
showed that: i) a non-random distribution of centenarians by place of birth and peculiar area (in the 
province of Nuoro) of exceptional male longevity were identified and called “blue zone” 83; ii) longevity 
clusters in families and occurs among the ascendants of a particular branch of the family 84. A peculiar 
characteristic of Sardinian familial longevity is that children born from mothers who later became 
centenarians had significant lower infant mortality when compared to children born to those women 
belonging to the same cohorts but who did not became centenarians 85. Thus, history of familial longevity 
contributes to increasing the odds for an individual's longevity, as reported in a study of 1,700 sibships from 
families of centenarians in the New England Centenarian Study 86. Moreover, centenarians offspring are 
characterized by a better health status when compared with age-matched controls born from parents who 
died before reaching the expected lifespan for their cohort 87. 
However, not only genes but also cultural and ecological dynamics cluster in families, especially in small 
populations that maintain local tradition and where marriages occurs within the same (or in any case very 
close) small communities (such as in Nuoro) 84. One clear example of the effect of the social and family 
structure on the genetics of longevity come from two studies in different populations such as Dutch and 
Calabria (South Italy) 88,89. The first found that spouses of long-lived partner, even sharing most of their 
adult life with their partner, did not present any advantage in term of survival, suggesting that the effect 
observed were mainly linked to genetic factors. On the contrary in South of Italy (Calabria) female spouses 
of long-lived siblings also live longer than members of the corresponding birth cohort indicating that 
females may benefit more than males of a favourable environment to become centenarian.  
These observations constitute the strength of the study, as they clarified to what extent the study of 
genetic of longevity may depend on familial, social structure and anthropological habits. Also in the Long 
Life Family Study (LLFS) – a longitudinal family-based study of longevity and healthy aging – spouses of 
members of long-living families tend to be healthier than a sex- and age-matched members of the general 
population 90. The underlying mechanism at the basis of these observations could be cultural, 
environmental and social but also genetic. Assortative mating based on characteristics such as 
anthropometric measures, behaviour, educational level, cognitive abilities which all have substantial 
genetic components may be a mechanism. A high degree of genetic similarities of spouse pairs, particularly 
for older generations, have been identified, and provide evidences for ancestry-related assortative mating 
also in families selected for longevity 91. The first studies and hypothesis of assortative mating in human 
longevity date back to 1914 and are based on the fact that familial longevity was a trait that families could 
be proud of. Assortative mating, differently from high level of inbreeding that affects the frequency of all 
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loci independently, is a phenotype-based assortative mating  (driven by different factors such as 
educational level, socioeconomic status, language, behaviour, culture etc.) and can change LD and the 
distribution of the genotype frequencies of the loci involved in the assortment to an excess of homozigosity 
92. Accordingly a recent study showed that genetic variants linked to education predict longevity, suggesting 
that individuals with more education-linked genetic variants had longer-living parents 93. In addition also 
the parental genomes (usually ignored in genetic studies) seems to play a role as non-transmitted alleles 
can affect a child through their impacts on the parents and other relatives, a phenomenon recently called 
“genetic nurture” 94. 
3.3. The genetics of longevity: a population approach 
Longevity is highly context-dependent as demonstrated by many studies. What is quite new is that also 
genes and pathways that impact on longevity are also population-specific. The study about longevity in the 
Chinese population identified peculiar pathways linked to longevity that are context-dependent 95. It is 
likely that longevity could be achieved in a population-specific way, involving both public and private 
mechanisms 65,96 and could be conceptualized as a sort of “convergent phenotype” 41, reached by context-
specific mechanisms (genetic and non-genetic) that are in part public (at least for biological functions) and 
in part private of each population. 
Within this perspective: 
1) gene-environment interactions can be strongly influenced by the fast changing and population-specific 
environmental conditions, and thus the same alleles can exert different effects in different populations;  
2) allele frequency can reach high frequency in certain populations because of evolutionary dynamics such 
as migration, bottleneck, drift or positive selection that acted in the past.  
An example of the first scenario is TCF7L2 rs7903146-TT, the most significant genetic marker of Type 2 
diabetes associated with cardiovascular events. A study of Corella and colleagues showed that the 
Mediterranean diet is able to counteract the effect (in term of stroke) of the risk genotype, suggesting that 
a genetic association can be influenced by population-specific environmental factors 97.  
An example of the second scenario come from a genetic study on the Italian population where the 
frequency of variants involved in different diseases showed different pattern according to past 
environmental selective pressures. The study published by Sazzini and colleagues 98 considered more than 
500,000 SNPs in 780 individuals recruited in the Italian population and demonstrated that past local 
adaptations and different admixture events with continental and Mediterranean populations shape the 
frequency of risk variants for complex pathologies - type 2 diabetes and cardiovascular diseases among 
others - considering North to South cline. Variability between populations is not the only source of variation 
to consider in the study on the genetics of longevity. Subtle but concordant changes in allele frequencies 
across population that share geographic area but which differ for ecoregion, dietary components and mode 
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of subsistence have been reported 99. Thus the same adaptive allele may increase in frequency in certain 
populations in different geographic areas that share the same environment. The case of APOE is 
paradigmatic and described below in a dedicated paragraph. The same considerations apply to mtDNA and 
Y chromosome. Population variability, past expansion or bottleneck and demographic history (often 
different for male and female individuals of the same population) is at the basis of the distribution of 
mtDNA and Y chromosome genetic markers. This consideration is crucial because it is known that the pool 
of genetic variation is created through de novo mutations in each genome, and through the standing 
genetic variation. This scenario will differ across populations, and since each population is exposed to 
different selective pressures as a result of inhabiting distinct spatial and temporal environments, mtDNA 
variation, Y chromosome variability and co-evolutionary trajectories of mitonuclear co-adaptation are 
predicted to be population-specific 79.  
3.4. The genetics of longevity in different socio-economic settings  
The social and ecological dimension is a further niche constructed by humans that plays a major role in the 
genetics of complex traits. It is well known that socio-economic factors may impact on human longevity. 
Longevity and the aging rate can change according to social factors, and one of the most striking example 
for longevity come from the city of Glasgow were higher level of mortality have been registered in 
persistently deprived areas 100. Another example is the case of Korea: South Korean population experienced 
a rapid increase in economic condition becoming one of the most developed nations; on the contrary the 
North Korean population remains one of the poorest countries. North Korean had 0.7 centenarians /1 
million persons in 1925 and 2.7 centenarians/1 million persons in 2010 and South Korean population 
showed 2.7 centenarians/1 million persons in 1925 and 38.2/1 million persons in 2010 101. These 
demographic data open new insight for the study of the genetics of human longevity as genetic influence in 
the same population may change according to social pressures as also demonstrated in a study by Rimfeld 
and colleagues 102. They considered 12,500 individuals from Estonia and demonstrated that during the 
Soviet era 2% of the variance seen in educational and success was due to differences in genetic factors and 
that this number increased to 6% after independence 102. Two recent studies investigated the effect that 
the socio-economic status at birth exerts in whole life mortality and showed that illegitimacy of the birth 
and parental occupation (in particular paternal one) were associated with an increase in mortality at all 
ages 103,104. The most obvious explanation of these differences is that socio-economic status impacts on 
nutritional profile, stress and exposure to infections, but recent data showed that epigenetic modifications 
(and in particular DNA methylation) may "recode" information of the father's environmental exposure and 
then be transmitted to the offspring 105–107, supporting the crucial role of evaluating these factors for the 
missing heritability. Moreover, it has been suggested that - even if social interactions tend to reduce during 
aging -  the maintenance of social connections help to live longer 108 and is associated with lower mortality.  
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In fact individuals with social relationships have an higher probability of survival (50% greater) compared to 
those individuals characterized by few and poor social interactions, as demonstrated by a meta-analysis of 
308 849 individuals, followed for an average of 7.5 years 109. On the contrary, the absence of interactions 
with the families and in particular with grandchildren can be associated to a higher susceptibility for 
depression in the elderly 110. Data on the role played by the behavioural genetics in determining these 
social interactions has not been analysed.  
These studies highlight the importance of social interactions when addressing the factors which contribute 
directly or indirectly to healthy survival and longevity, including the genetic ones. Accordingly, we propose 
the following considerations regarding the genetic of longevity in humans: 1) the genetic of longevity is 
highly dependent from the socio-economic status, as the process of remodelling and the genes favouring 
longevity appear to be different in different socio-economic backgrounds. As an example   the results of the 
Health and Retirement Survey (HRS) in  USA showed  by an analysis of 9,317 adults (>65 years old)  that the 
genetic predisposition to major chronic health conditions and the definition of "genetic risk variants" are 
strongly related to socio-economic status 111; 2) new socio-economic conditions have emerged recently, 
such as the obesogenic environment. Thus, genes that favoured  longevity a century ago (for example 
during the First World War or when antibiotics did not exist) are likely  different from the genes that favour 
healthy aging today; 3) social interactions may shape genetic variability. Genes may evolve through positive 
selection according to their effects on social behaviour (called also indirect effect, because they confer a 
characteristic crucial to boost social interactions). The most striking example in the study of human 
evolution is the language gene FOXP2. This gene, even if does not encode for social behaviour traits in any 
mechanistic sense, indirectly increases the possibility of social interactions between  individuals and likely 
its frequency increased owing to the advantage in social behaviour. Likewise genes involved in testosterone 
profoundly changed during evolution under social selective pressure when humans changed the way of 
subsistence, e.g. from nomadic to settled societies and thus force to more numerous social interactions. 
4. THE GENETICS OF HUMAN LONGEVITY: THE MAIN FINDINGS 
4.1. From whole genome sequencing (WGS) 
To date whole genome sequencing is the most informative approach for genetic analysis. However, this 
technology is also the most recent in terms of availability and the reduction in term of costs/sample 
occurred in the last few years have radically changed the approach to genetic studies. 
While the first studies on the genetics on human longevity were based on candidate gene analysis, 
to date the approach is based on the use of genome-wide techniques to identify the most informative loci, 
and functional studies both in vitro and in vivo constitute the last step of the analysis. The main advantage 
of whole genome sequencing is that it allows the study of the existing genomic variability of each individual 
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(both in coding and non-coding regions) without using imputation process, that may include some bias due 
to the reference population. To date the only few whole genome sequencing studies on the genetics of 
human longevity are available: (i) the first studies were performed  by Sebastiani and colleagues 112 and by 
Ye and colleagues 113 , and analysed few individuals reaching the extreme decades of life. The Sebastiani’s 
study published in 2011 sequenced two supercentenarians (>110 years old) but the low number of subjects 
does not allow any statistics. However, an interesting data emerged: the two subjects likely reflected two 
different strategies to reach the last decades of life. The female was characterized by significant stretches 
of homozygosity across many chromosomes, consistent with inbreeding amongst her ancestors, and she 
carried only 5 out of 16 common variants selected for their role in metabolism that resulted associated to 
longevity in GWAS studies.  The same analysis in male showed no similar stretches of homozygosity, and 11 
out of the 16 common variants associated to longevity. Overall, these results suggested that the woman 
was enriched for private mutations that promote exceptional longevity (due to her familial genetic 
background). 
(ii) The second study 113 considered a monozygotyic twin pair reaching 100 years and owing to the 
peculiarity of the samples  the study also investigated the prevalence of somatic mutations. (iii) The third 
study published in 2014 by Gierman 114 and colleagues considered 17 supercentenarians (110 years or 
older) of European ancestry, but the use of public available genomic data as control reduces the efficacy of 
the analysis (reducing the number of variants to analyse). The main findings can be summarized as follows: 
i) no significant evidence of enrichment for a single rare protein-altering variant or for genes harboring rare 
protein altering variants in supercentenarian compared to controls was found; ii) the gene most enriched 
for rare protein-altering variants in this cohort of supercentenarians was TSHZ3, but the replication on a 
second cohort of 99 long-lived individuals failed.  iii) The most recent paper - and also the largest in term of 
sample size - was published in 2016 by Erickson and colleagues 115, but the authors studied an "healthy 
ageing" phenotype, based on self-reported data (called by the author Wellderly, in subjects aged 84.2 ±9.3 
years). The age range of the study indicates that very limited information regarding longevity have been 
investigated 116.The main result of this study is the association with healthy aging in loci in the  COL25A1 
gene encoding for a protein secreted in the brain and associated to amyloid plaques. 
Thus, sequencing study on longevity are emerging, but available data did not allow a real "discovery" phase 
in comparison with pre-existing data. Few samples and the lack of controls impair the interpretation of the 
sequencing data. 
 
4.2 From genome wide association studies (GWAS) 
The literature regarding exome sequencing in human longevity is not so rich, and only few studies used this 
type of protocol 117–119.  The vast majority of data regarding GWAS are based on high-dense microarrays 
analysis (usually Affymetrix or Illumina) that thanks to imputation process can be compared between 
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different cohorts and populations for millions of SNPs. Even if the purpose of this review is not to elucidate 
the limitation of imputations process a detailed description on this topic can be found in 120,121. GWAS can 
be ideally divided into two major types according to the considered phenotype: the first is focused on aging 
and longevity evaluates the genotype of each individual correlated with the phenotype of the individual 
itself; the second includes parental longevity and evaluates the genotype of each individual correlated with 
the age phenotype of the parents. In Table 1 an overview of all (as far as we know) the GWAS studies are 
reported. The purpose of this section is not to purely describe the genes emerged from each study as other 
excellent reviews have been produced on this topic, but to let clarify the main conceptual assumptions, 
results and methodological strength/limitation of the available studies which in a sense have revolutionized 
the field. 
4.2.1 The link between longevity variants and age-related diseases emerges from GWAS studies 
The relationship between aging and chronic age-related diseases is based on epidemiological evidence and 
experimental data that aging is the major risk factor for such pathologies and assumes that aging and 
chronic age-related diseases/geriatric syndromes share a common set of basic biological mechanisms. Age-
related diseases  can be conceptualized as accelerated aging and that aging and age-related diseases  are 
part of a continuum, the two extremes being represented by centenarians who largely avoided or 
postponed most age-related diseases, and patients who suffered one or more severe age-related disease in 
their 60s, 70s, and 80s 4. 
Longevity GWAS provided important evidences supporting the tight interconnection between aging and the 
age-related diseases. Many "longevity variants" have been identified, but function analysis showed that 
most of them are involved in age-related diseases. APOE/TOMM40 - that emerged from the vast majority 
of studies 8,38,122–127 - is a remarkable example as it is involved in Alzheimer's disease onset, in CVD and 
cancer (see Table 2). Deelen and colleagues 124 in their GWAS study on European longevity in the 
framework of the GEHA project identified a novel locus on chromosome 5q33.3 associated with survival 
beyond 90 years, and replicated the locus TOMM40/APOE/APOC1. In particular the SNP, rs2149954-T, in 
chromosome 5q33.3 is associated with low blood pressure, and they showed that minor allele (T) carriers 
present lower mortality risk for CVD, eventually linking longevity with a lower risk for stroke. The authors 
identified for the first time a real "longevity locus" as the association observed is positive, meaning that 
centenarians are characterized by an high frequency of the alleles associated with low blood pressures 128. 
The study of Fortney et al 40 described for the first time the overlap at genome-wide level between 
longevity and age-related diseases. The approach developed by Fortney and colleagues provides to each 
SNP an age-related risk weight (the approach was called iGWAS, informed GWAS). In particular, it revealed 
that in longevity there is a reduction of the genetic risk for artery disease, Alzheimer's diseases, diastolic 
and systolic blood pressure, three blood lipid traits (triglycerides, total cholesterol, LDL), chronic kidney 
disease and bone mineral density. Beekman et al.129, and Sebastiani et al. 38 used a different approach to 
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investigate disease risk alleles in longevity and utilized sets of disease SNPs to construct genetic risk scores 
(or polygenic risk scores 111). They found no significant differences between centenarians and controls, 
concluding that disease risk alleles do not compromise human longevity. These contrasting results are likely 
related to the different statistical tools applied on the same question. However to move a step forward on 
this hot topic it is necessary to carefully study each genetic risk alleles in centenarians and patients 
matched for geographical origin. 
In any case, as expected, from available data the enrichment of age-related disease variants has never been 
observed in centenarians, in accord the prediction of geroscience that aging is the greatest risk factor for a 
majority of chronic diseases, driving both morbidity and mortality. Thus, we surmise that the geroscience 
architecture 3  has missed the eighth pillar: genetics. This consideration is supported by a recent review on 
progeroid models that highlighted the notion that genetics has profound effects in determining the aging 
process: in particular, looking at lamin-linked progeroid disorders, it is clear that determinants of aging may 
originate from an altered genetic background 130. Accordingly, a GWAS study 131 identified a genetic 
correlation with longevity in the WRN gene, responsible for the Werner syndrome, a progeroid disorder 
characterized by premature aging 132,133 . 
4.2.2 Longevity depends on small-effect alleles 
The GWAS study of Yashin and colleagues 134 revealed the importance of including in the analysis also 
signals with p≤10-6 in the study of genetics of longevity, suggesting that the traditional p≤5*10-8 is likely not 
appropriate for this trait. This cut-off widely used in GWAS data in order to reduce the number of false 
positive may be difficult to apply to studies on longevity that are characterized by a small sample size owing 
to the fact that the recruitment of high number of centenarians, particularly from the same population, is 
often difficult and challenging. In our opinion the use of statistics need to be contextualize into the 
biological problem (in this case longevity) in order to identify the right trade-off between the risk of 
identifying false positive signals and the possibility to filter out biologically relevant signals that fall under 
this cut-off. To assess this problem Yashin and colleagues 134 tested the hypothesis that longevity depends 
on a number of small-effect alleles using 550k SNPs data in 1,173 genotyped participants of the 
Framingham Heart Study (FHS). They demonstrated that the joint influence of small-effect alleles on life 
span is both significant and substantial, explaining in part the numerous GWAS that did not find any p≤ 
5*10-8 result 122,126,131,135. This study let emerge the importance to evaluate non-additive (non-linear) joint 
genetic influence (epistasis) to investigate the “genetic dose – phenotypic response” relationship in 
longevity. Moreover, this result impacts on genetic calculations such as heritability, whose main 
assumption is the additive nature of genetic component of phenotypic variations. 
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Figure 6. Longevity depends on small-effect alleles, and new type of analysis is required to analyze this trait and to 
extract the information from available genetic data. Missing heritability evaluations indicate that the additive model 
alone is not sufficient to cover all the genetic contribution to “genetic dose – phenotypic response” in complex traits. 
Non-additive interactions and epistasis should provide part of the human longevity missed heritability. Ecological space 
concept (right), proposes that genetics of longevity results from individual, time- and space-dependent GxE 
interactions. ID indicates different non-centenarians individuals and a centenarian, in red and green, respectively. 
 
New mathematical model to calculate epistasis and effective tools to reduce the high dimensionality of the 
data, and the use of both additive e non-additive interactions are needed (Figure 6).  
A new method for the analysis of small-effect alleles is discussed in the paper of Boyle and colleagues 136 . 
They proposed an "omnigenic model" based on the definition of core and peripheral genes. According to 
the authors, the first constitute a network of genes whose mutation lead to the strongest effects on the 
trait under study, while the second class of genes includes all the genes with no apparently relevant effects 
on the trait. They observed that a large proportion of the genetic contribution to a complex trait comes 
from peripheral genes that are only a few steps (in term of distance between the nodes of the network) 
from the nearest core gene and thus may have an effect on the trait in specific tissues. Boyle et al. propose 
that complex traits, such as longevity and age-related diseases, are the results of many processes that 
involve different cell types and tissues, and the role of the genetic variants has to be contextualized in such 
locations 136. 
4.2.3 GWAS analysis showed monotonic as well as non-monotonic age patterns of allele frequencies 
The study of different allele/genotype frequencies in distinct age classes has been used as evidence of the 
presence of genetic influence on survival 137. With this method, called "gene frequency methods" (GF), it 
was possible to divide variants in "frail", "neutral" or "robust" according to the trends showed with aging 
(as reported in Figure 7). GF is based on two main assumptions: i) the allele frequencies in all the 
considered birth cohorts are the same; ii) mortality for genotypes does not change between birth cohorts. 
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This approach was adopted in two studies 138,139. The change of allele frequency with age may follow linear 
trends (monotonic) or non-monotonic patterns (usually U-shaped patterns or constant until a certain age 
and then linear) in which allele frequency decreases to a given age but then increases, reflecting trade-offs 
in their effect at young and old ages. 
  
 
Figure 7. Gene frequency methods. Different allele/genotype frequencies in distinct ages. If initial alleles frequencies in 
all birth cohorts are identical and if mortalities for genotypes do not depend on the birth cohorts this approach 
identified linear trends (monotonic) or non-monotonic patterns (usually U-shaped patterns or constant until a certain 
age and then linear) of allele frequencies. These trajectories may reflect trade-off in the effects at young and old ages. 
  
Non monotonic trends have been suggested to correspond to genetic variants whose effect on mortality 
risk change with increasing age, from detrimental to beneficial (or vice versa) 138. 
Such trajectories increase the complexity of the study of genetics of longevity because indicate that the 
effect of a given allele varies according to the changes of the internal environment that occur from young 
and adults to the oldest old 140,141. This feature, called "complex allele timing" by Benedictis and Franceschi 
(2006) points out the fact that genetic risks or protective factors are likely age-specific. The concept of 
"allele timing" should not to be confused with that of antagonistic pleiotropy 140. According to the 
antagonistic pleiotropy theory 142 the same allele can act not only on the probability of survival at 
young/adult age but also on antagonistic traits (for example fertility or traits link to disease) later on,  in a 
different period of life. For example an allele may confer high fertility (or protection from infections) early 
in life and the same allele might be deleterious for survival late in life. The allele timing is instead linked to 
the adaptive process of remodelling of cellular and molecular mechanisms that occurs lifelong. According to  
the remodelling theory of aging 2,143 the same allele can exert different effects on survival because its 
function change (e.g. its gene expression) according to the internal microenvironment that in turn changes 
with age). In this case there is no pleiotropy as the effect is on the same traits. 
An example of genes whose variants follow a U-shape trend can be found in the paper of Bergman and 
colleagues, regarding KLOTHO (an aging  gene associated with low HDL and reduced CVD risk) and LPA 
(lipoprotein A) genes 144. Other studies highlighted the importance of identifying allele frequency changes 
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during aging as a method of distinguishing between longevity and buffered-deleterious genotypes 145. Some 
risk alleles with age-related U-shaped frequency may be buffered by other "pro-longevity" variants, as in 
the case of CETP (favourable) genotype that was demonstrated to neutralize the deleterious effects of the 
LPA gene 144,145. To this regard it is interesting to note that the product of LPA gene, i.e. lipoprotein(a) 
[Lp(a)], a widely accepted risk factors for atherosclerotic vascular diseases, did not change with age until 
the extreme ages, and a number of atherosclerosis free centenarians had high Lp(a) serum levels, together 
with low HDL-CT and relatively high TG 146. These data support the hypothesis that a continuous and 
complex reshaping of lipid metabolism occurs in physiological aging, likely contributing to longevity. 
4.2.4. GWAS remarks the population specificity of longevity 
Other GWAS studies 95,122,147 let clearly emerge the importance to take into account population 
stratification in genetic studies on longevity, in accord with the above-described ecological perspective. The 
study of Zeng and colleagues on Chinese centenarians is particularly interesting, as the demographic history 
of the country reduces, at least in part, population stratification and concomitantly allowed the inclusion of 
an unprecedented number of centenarians. The authors identified both shared and population-specific 
genes and pathways involved in longevity. They confirmed the loci in APOE and chr5q33.3 and identified 
new loci in IL6, the well-known "gene of gerontologist", and in ANKRD20A9P. It is to note that the p-values 
in the cohort of Northern Chinese (1115 centenarians) and in Southern Chinese (1063 centenarians) did not 
reach 10-8, while the combined analysis of the two reached the GWAS threshold. The relative homogeneity 
of the population and the extreme phenotype (all cases are within the one percentile of survival) support - 
as mentioned above - that suggestive, nominally significant signals are fundamental in the study of extreme 
longevity. The study highlighted also longevity pathways peculiar of the Chinese context (xenobiotic, starch 
and sucrose metabolism), as well as diet-mediated mechanisms, which can differ according to culture and 
ethnicity. A second study of Malovini and colleagues considered a population of South Italy and identified 
the association between longevity (defined here with an age range between 90 and 109) and a gene never 
described by any other study, i.e. CAMKIV gene. They also demonstrated by a functional study that CAMKIV 
is important in the activation of proteins involved in survival such as AKT, SIRT1 and FOXO3A.In general, 
these examples show that longevity is the result of "phenotypic convergence" 41 reached by context-
specific mechanisms (genetic and non-genetic) that in part are “public” and shared among individuals and 
in part are “private” in terms of population, family and individual specificity. In a 2006 paper De Benedictis 
and Franceschi suggested to conceptualize the Italian and European centenarians as "phenocopies", 
according to the classical definition of subjects who share the same phenotype (i.e. longevity) reached by 
different gene/environment combinations 148. 
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4.2.5. Results from Genome wide linkage analysis (GWLS) 
GWLS searches for chromosomal segments that co-segregate with the phenotype through families. The 
characteristic of linkage studies is that this approach is highly informative when highly penetrant variants 
cause the disease/phenotype as they rely on the presence of a single mutation of very strong effect, while 
genetic heterogeneity, incomplete penetrance and environmental phenocopies reduce the power of this 
approach. GWAS and GWLS are complementary and not concurrent 149. Accordingly, even in the same 
population loci identified through GWLS might not overlap with those identified by GWAS. In the field of 
longevity one of the first study based on linkage analysis was performed in 2001 by Puca and colleagues in 
a limited number of samples, and they detected linkage at 4q25 (LOD =3.65) but subsequent studies failed 
to replicate this signal 150–152. The first GWLS on a large cohort of European ancestry was performed in the 
GEHA Study on 2118 European 90+ sibships (couples of brothers and sisters both older than 90 years of 
age) 8. The study identified four regions linked to human longevity, and one of them was the APOE region. 
The authors suggested that the absence of APOE-e4 haplotype in nonagenarians is quite expected, while 
the APOE-e2 haplotype had to be considered a longevity gene as the linkage they observed was mainly 
explained by its high frequency.  
4.2.6. Parental lifespan: a different approach in GWAS studies 
The availability of GWAS data in large population cohorts with thousand and hundreds of thousands of 
probands ,supplied with the age of death of their parents, opens to the possibility to correlate their 
longevity genetics with parental longevity phenotype, following the assumption that the "age-of-death for 
the parents is a measure of longevity" 153–156. This starting assumption can be misleading for the following 
reasons: i) these studies investigate the association between offspring genotype with parent phenotype 
(i.e. parent's lifespan), thus the genetic association is indirect and based on the heritability estimation of 
the life expectancy trait; ii) these studies address the life expectancy phenotype and draw conclusion 
regarding longevity that is a different phenotype as discussed in a previous paragraph.157 Moreover, this 
approach underestimates the relationship between genes and the environmental changes that occur 
generations after generations, so that genes that impact on longevity may be different in different birth 
cohort (Figure 8). Industrial progress, improvements in living conditions, changes in nutrition, and other 
transformations in the human environment (including the emerging obesogenic environment) may have 
different survival effects on individuals with similar or different genotypes, as previously hypothesized 137 
and recently supported 137,158.This scenario is further complicated by the fact that for certain genes GxE 
interactions change with age159.  
APOE and CHRNA3/5 (nicotinic acetylcholine receptor) are the genes identified and replicated in the 
highest number of study on parental lifespan. APOE will be thoroughly discussed in one of the following 
paragraph, while CHRNA3/5 was never identified in other studies on human longevity and it has been 
associated with traits linked to smoking behavior (nicotine dependence, lung cancer, chronic obstructive 
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pulmonary disease) 156.  Moreover, some authors suggested that CHRNA3/5 exhibits sexually dimorphic 
effects on parental mortality, driven mostly by younger male deaths 160.  
 
Figure 8. Mortality curve of two distinct birth cohorts, 1891 and 1951, are represented. The curves reproduce general 
mortality dynamics of Western countries. These two tendencies are paradigmatic of the dramatic changes in the GxE 
occurred in the last century. Vaccination campaigns, improvement of hygiene and nutrition, education and antibiotics 
treatments set infancy mortality to zero around the end of the Second World War. These changes have concrete effects 
in the genetic pool of Western populations andand selective pressure is dramatically reduced, if not disappeared. Other 
factors further influenced the Western populations gene pool  i.e. the reduction of fertility and the onset of vast 
migratory events. Concomitantly we experienced the gradual onset of obesogenic environment that is at the basis of 
the obesity pandemic that many Western countries are facing. Such new detrimental conditions are relatively recent, 
and since the clinical manifestations of dismetabolic conditions have and adult-elder onset, we have not experienced 
yet the health load of such changes. Overall this representation shows clearly that to study the genetic of longevity  
GxE interactions and the birth cohort and population effects have to be considered. 
 
4.3 LONGEVITY GENES IN CARDIOVASCULAR DISEASES 
In this section a subset of the most studied and relevant genes identified in the study of the genetics of 
longevity are described focusing on the link with CVD. Then, a study using the novel approach of Mendelian 
randomization is reported in order to investigate the causal effect between lipid profile, genetic variation 
and longevity. Common genes identified in longevity studies and in studies on CVD are reported in Figure 9 
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Figure 9. The genes involved in longevity according to GenAge database and the one involved in CVD according to 
CardioGenBase database (http://www.cardiogenbase.com/) have been compared and reported through a Venn 
diagram. Genes in the intersection (N=147) have been listed.  
 
4.3.1. Apolipoproteins and APOE/TOMM40 
Apolipoproteins are soluble molecules present in plasma and many genetic studies showed their role in 
longevity and in age-related diseases 25. The idea that they are druggable explains the number of studies 
devoted to the different apolipoproteins. Some associations with longevity were described for APOB-VNTR 
in Italian centenarians 161,162, for APOC1 in the Bama populations 163, for APOC3 (-641C allele) in Ashkenazi 
Jewish 164 . These genetic variants likely influence lipoprotein profile, cardiovascular health and insulin 
sensitivity. Among all these genes the most replicated is the region of APOE/TOMM40 8,38,122–127, that is 
considered the "master" longevity gene 165. The data show a negative association with APOE-e4 allele 
suggesting that it has to be considered ‘‘frailty’’ rather than a true longevity allele 166,167. On the contrary an 
enrichment of APOE-e2 allele was observed in long-lived individuals 165,168,169 and this suggests a protective 
role of this allele supported by a positive association between APOE-e2 and healthy cognitive status 169,170.  
APOE is involved in lipid metabolism, by regulating production, conversion and clearance of lipoproteins, 
and is expressed in different tissues (adipose tissue, nervous system and liver) and cells (macrophages) 171.. 
APOE-e4 is associated to Alzheimer's and CVD 123,124,126,172–177.TOMM40 encodes for a protein that forms a 
channel in the outer mitochondrial membrane and is crucial for mitochondrial health. Under this scenario 
three main questions emerge:  
1) why APOE-e4 has not been replaced by natural selection with the health-beneficial APOE-e2 allele? 
APOE-e4 is the ancestral allele typical of modern humans while APOE-e2 and APOE-e3 evolved around 
200,000-300,000 years ago 178. An hypothesis proposed by Finch and Stanford 179,180 suggests that APOE-e4 
confers resistance to diseases associated with meat-eating. APOE-e4 is also associated with improved 
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cognitive function in Amazonian forager-horticulturalists with a high parasite burden 181, thus conferring an 
advantage in a specific environment. This and other results led to the hypothesis that the high frequency of 
APOE-e4 was maintained since it confers protection in environments where infectious diseases are a 
relevant cause of mortality 182. APOE gene also influences fertility and APOE-e4 positive women had have 
significantly higher levels of mean luteal progesterone, suggesting increased fertility, that can contribute to 
explain the conservation among different populations of this “deleterious” allele 183.  
2) Why the association of APO-e4 with longevity seems to vary across different populations? APOE-e4 show 
a cline in Europe (from about 20% in North Europe to about 6/7% in Southern Europe), and a high level of 
frequency diversity among populations 184. Today, the frequency of the APOE-e4 allele in human 
populations follows a sort of U-shaped latitudinal trajectory, where the highest frequencies (up to 
approximately 40–50% of the population) are observed at equatorial and high latitudes and lower ones at 
middle latitudes 185. This evolutionary-determined allele frequency distribution makes difficult to assess 
longevity association in population where APOE-e4 is present at very low frequency (around 6-7%) such as 
in Southern Italy as shown in the study of Deelen et al 124. Moreover, APO-e4 is a pleiotropic gene, showing 
many interactions with the environment and in particular with diet, thus creating population-specific and 
context-dependent gene-environment interactions (for a detailed review see 186). 
4.3.1.1. Cardiovascular risk - APOE has been associated to cardiovascular health in a recent meta-analysis. 
The study identified a single-nucleotide polymorphism (rs445925) in the APOC1/APOE region that was 
associated with clinical ideal cardiovascular health (defined according to AHA 2020 goals 187) at genome-
wide level of significance (P<2.0 × 10-9) 188 . Moreover APOE (rs7412) has been identified in a study on the 
genetic architecture of coronary artery disease 189. A possible mechanisms for the link was proposed by Li 
and colleagues, who suggested that ApoE regulates the expression of anti-inflammatory microRNA (miR-
146a) in macrophages and intravascular delivery of miR-146a mimetics can inhibit atherogenesis in mouse 
models 190. The data about APOE are summarized in Table 3.  
4.3.2. IGF-1 and FOXO3  
Genetic variance in the insulin-like growth factor -1 (IGF-1) pathway has been associated with longevity in 
several studies. IGF-1 and related genes is one of the most conserved genetic determinants of longevity 
across a variety of model organisms 191. IGF-1 pathway is involved in a broad spectra of functions related to 
metabolic regulation and energy management192.There is evidence that in centenarians IGF-1 circulating 
levels are significantly lower 193, and a positive association between higher circulating IGF1 levels and all-
cause mortality, but not  CVD events, has been reported 194. In 2003 Bonafè et al 195 in a study on Italian 
centenarians reported an association between a SNP in the IGF-1R gene and low plasma levels of IGF-1, and 
the allele responsible of the low IGF-1 levels was found over-represented in centenarians 196. Suh et al 197 in 
2008 sequenced the IGF-1R gene in a cohort of Ashkenazy Jewish centenarians and they found that 
centenarians were enriched in genetic variants capable to reduce the efficiency of IGF-1R, generating a sort 
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of IGF1 resistance. According to a 2011 study on an Italian cohort of subjects older than 85 years of age, the 
IGF-1R rs2229765 polymorphism favour longevity in male carriers of the homozygous A allele 196.   
Forkhead box O3 (FOXO3) is a transcription factor that exerts a down-regulation activity on IGF-1 pathway, 
and its genetic variability is one of the most consistent longevity heritable factors in humans. Sequencing 
studies on this gene showed that the alleles linked to longevity reside in the 3’ region 198–200.  
In a study by Flachsbart et al. 201 the authors applied a combined candidate-gene sequencing – SNPs 
genotyping approach and identified variants linked with longevity in three North European populations., i.e. 
France, Germany and Denmark. In particular, two variants, rs4946935 and rs12206094, were identified, one 
of them (rs4946935) having been previously identified as longevity gene 198. A functional validation of these 
two non-coding variants was performed, and the results show that the longevity-associated allele promotes 
the expression of the gene. In a broad meta-analysis on 30884 individuals of European ancestry 202 the 
authors studied the genetic association with circulating levels of IGF-1 and IGF binding protein–3. This 
original approach allowed the authors to establish a significant association with the circulating levels of IGF-
1 and the rs2153960 in FOXO3 gene. A number of loci involved in growth hormone (GH) path also emerged, 
in particular showing significant associations for the IGF-1, IGFBP3, IGFALS, GHSRASXL2 and CESLSR2 genes, 
and many of the identified variants were also associated with elderly health traits and with longevity. 
Functional studies suggested the existence of an HSF1-FOXO3 axis in human cells that could be involved in 
stress response 203. FOXO3 became physically connected, through chromatin looping, with 46 other genes 
on chromosome 6 thus forming an aging hub 199. 
4.3.2.1. Cardiovascular risk. IGF1 is implicated in CVD and evidences suggest that IGF-1 has a vascular 
protective role for the treatment of chronic heart failure and its deficiency may cause CVD 204. Moreover, 
IGF-1 has a pleiotropic action in hearts and cardiac activation of IGF-1 receptor (IGF-1R) protects from the 
detrimental effect of a high fat diet and myocardial infarction 205 . As far as we know, no evidence has been 
reported for FOXO3 and cardiovascular implications.  
 
4.3.3. IL6 
IL6, known as the cytokine of gerontologists 206, is a multifunctional cytokine that presumably plays its 
major role as a mediator of the acute phase of inflammatory responses and becomes detectable in 
advanced age and in conditions characterized by the presence of chronic inflammation. Elevated serum IL-6 
levels are associated with significantly increased risk of morbidity and mortality in the elderly 207. The 
previously-mentioned  GWAS study on Chinese centenarians 95 showed that the minor allele of rs2069837 
located in IL6 (chromosome 7p15.3) is the variant (intronic)  most significantly (negatively) associated with 
longevity, being significantly less frequent among centenarians than middle-age individuals in Han Chinese 
(odds ratio = 0.61; P = 1.80 × 10−9), and alone explaining about 1% of the variance of the variance in 
surviving to ages 100 + from middle-age. A study on 323 Italian centenarians identified a significant 
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association between rs1800795-IL-6 (-174 C/G at promoter locus) and longevity, and showed that GG 
homozygotes decreased in centenarians males, suggesting a sex-specific detrimental effect 208,209. Other 
numerous studies showed the implication of SNPs located in IL6 in longevity 209–213.  
 The case of IL6 is peculiar as it constitutes a link between genetic susceptibility to inflammation, age-
related diseases and longevity. However, it is to note that the above-mentioned SNPs are not closely linked 
to IL6 plasma levels as the SNPs that is better associated to circulating IL-6 levels are located in IL6 receptor 
(IL6R rs7529229, rs8192284,  rs2228145), as demonstrated by a Mendelian randomization analysis in a 
study that showed that  IL6R signalling seems to have a causal role in the development of coronary heart 
disease 214,215.  
4.3.3.1. Cardiovascular risk Long-term increase of IL6 levels is associated with a high risk of coronary heart 
disease 216. A recent study identified a genetic variant (s7529229) associated with increased IL6 levels 
circulating in the blood but decreased IL6R signaling. The authors investigated the effect of the variant 
comparing it with the effect of anti-IL6R drug (tocilizumab). The results showed that the variant was 
associated with the same biological changes as the inhibiting drug. The authors suggested that genetic 
studies in populations could be used more widely to help to validate and prioritize novel drug targets, and 
IL6R blockade could provide a novel therapeutic approach for coronary heart disease 215. Also the  G allele 
of -174 C/G polymorphism was found to be associated with increased risk of CVD and other age-related 
diseases such as Alzheimer’s dementia  and T2D 217–219.  
4.3.4. SIRTUINS 
The link between sirtuins and longevity can be attributed to discoveries in animal models (in particular in 
C.elegans and in Drosophila), and the sirtuin story dominated the agenda of several meetings on ageing. 
However in 2011 some researchers claimed that there was a technical problem: the study published in 
Nature demonstrated the lack of effects of sirtuin overexpression on aging after proper standardization for 
genetic background in both C. elegans and Drosophila 220.  
In humans 7 sirtuin genes (SIRT 1-7) exist, but only few of them are involved in longevity,  and studies on 
the effects of genetic variants in human sirtuins on lifespan are limited, and can be summarized as follows: 
(i) SIRT1 did not showed any genetic association with human longevity 221,222 but it influenced survival in 
T2D patients in interaction with dietary niacin and smoking 223; (ii) SIRT3 has been associated with 
adaptations to nutrient stresses, such as fasting and calorie restriction. A study by Rose and colleagues in 
2003 224 found that in males the TT  genotype (G477T) increased survival (p=0.0272), while the GT genotype 
decreases (p=0.0391) survival in the elderly. The second study investigated the frequency of VNTR 
polymorphism (72-bp repeat core) in intron 5 in 945 individuals (20-106 years) and found that the allele 
lacking enhancer activity was absent in males older than 90 years 225. The third study is a meta-analysis of 
SIRT3 SNPs among Italian, French and German centenarians, and no robust positive association was found; 
(iii) SIRT6 is a chromatin-associated protein promoting heterochromatin silencing at repetitive DNA 
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sequences, repressing the activity of L1 retrotransposons (that become more active in somatic tissue during 
aging) thus increasing genome stability 226. A study performed on the Iowa population found association of 
the SIRT6 SNP rs107251 minor allele homozygotes (TT) with a decreased lifespan of 5.5 and 5.9 years  227, 
confirming a previous study by Sorensen et al. about Danes longevity 228. Negative results emerged in a 
study on longevity in Han Chinese centenarians229.  Donlon and colleagues 230 tested 459 SNPs in 58 
candidate genes, of which 47 genes were selected as the most differentially expressed in mice under calorie 
restriction, in a cohort of 440 subjects aged 95 years and over in comparison with controls. Among these 
genes SIRT7 and SIRT5 showed for the first time a positive association with longevity. 
 
4.3.4.1 Cardiovascular risk- SIRT1 has a protective effect against CVD and through its deacetylase activity 
regulate exerts many functions, promotion of angiogenesis being one of them 231. Different polymorphisms 
in SIRT1 gene have been associated to susceptibility to CVD 232 , blood pressure in Japanese 233and carotid 
plaque 234.  Moreover, a study in the Iranian population found that the SIRT1 rs3758391-CC genotype was a 
risk factor for CVD and that carriers of this genotype were at 3- or 3.7-fold increased risk of CVD than 
subjects with the TT genotype, respectively 235, but further studies are needed to validate the role of SIRT1 
genetic variations in cardiovascular impairment.  
 
4.3.5 Somatic mutations and clonal hematopoiesis  
All the above-mentioned genes reported the variability observed in the germline, however a further 
example of genetic variants affecting longevity and cardiovascular risk has been described. The paper of 
Jaiswal and colleagues 236 demonstrated that there are recurrent somatic mutations in genes involved in 
hematological malignancies. This condition is called “clonal haematopoiesis”, or “clonal haematopoiesis of 
indeterminate potential” (CHIP). Clonal haematopoiesis is a functional phenomenon in which a 
hematopoietic stem cell has acquired a survival and proliferative advantage. By whole-exome sequencing a 
common, age-related expansion of hematopoietic clones carrying recurrent somatic mutations, most 
frequently loss-of-function alleles in the genes DNMT3A, TET2, and ASXL1, was found. This condition has 
been shown to be associated with increased cardiovascular risk and reduced overall survival among 
persons with expanded clones, as compared with those without clones, with an effect much larger than 
that which can be explained by hematologic cancers alone. This somatic condition seems to play a crucial 
role in aging and such clones rarely accumulate in persons younger than 40 years of age, but are present in 
more than 10% of persons older than 70 years of age. Persons with such mutations in the absence of any 
other hematologic abnormalities have been defined as having CHIP. It is interesting to note that in 
centenarians the prevalence of CHIP is very low (around 2,5% in semisupercentenarians) 237. These results 
shows that centenarians seems spared from the exponential increase of CHIP observed after the age of 70 
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years in previous studies, suggesting that the capability to avoid the clonal expansion of such mutations 
might have contributed in protecting centenarians from CVD.  
 
4.4. Mendelian randomization in the study of the genetics of longevity 
Mendelian randomization (MR) is a recent analytical method applied to observational study that aims to 
infer and examine causal effects when possible confounding factor may cause indirect association. 
However, it is to note that this approach is based on the assumption that the gene(s) under study is(are) 
not pleiotropic and thus it is likely not suitable for many genes like APOE  238. An example is the recent 
study aimed at  verify the  association between  genetically-predicted tryglyceride levels (rs662799 in 
APOA5 gene)  and  longevity in a Han-Chinese population 239. The study started from the following 
observations:  i) the rs662799-C allele was found to be associated with higher triglyceride levels; ii) 
triglyceride levels were also associated with longevity. Thus MR was applied to assess the possible causal 
link between genetically predicted (on the basis of rs662799) triglyceride levels and longevity. MR analysis 
revealed that genetically-predicted triglycerides were not associated with probability of longevity while 
serum triglycerides were observationally strongly associated with longevity 239. A second study 240 analyzed 
three Dutch cohorts starting from observational studies in older subjects that did not show (or show 
inverse) correlation between cholesterol levels and mortality. In this study MR was applied starting from a 
genetic risk score (GRS) including 51 SNPs associated with LDL-C levels.  Interestingly, the authors showed 
that individuals with a genetic predisposition for longevity are characterized by a lower LDL GRS, and 
concluded that a beneficial LDL GRS is associated with familial longevity. 
5.  HOST GENOME AND ITS INTERACTIONS 
 
Longevity is not only the outcome of GxE interactions but it is the results of the interaction(s) between 
“genomes” (mtDNA, microbiome and nuclear DNA), environment and somatic mutations occurring during 
aging in all the genomes that reside in the human organism itself (referred as holobiont/metaorganism). 
Thus, the phenotype emerges from multiple levels of selection that operate simultaneously on the 
holobiont/metaorganisms 241, and the study of such complex interactions in longevity is still in its infancy. 
Somatic mutations occurring in the different genomes (Figure 10) are inherited from cell to cell and their 
frequency change during development, following evolutionary dynamics similar to those applied to 
population genetics (migration, drift, selection etc...), so that the term "somatic evolutionary genomics" has 
been recently proposed to indicate the study of such events during lifetime 242. These mutations may cause 
variable genetic mosaicisms that could hide important implications for the study of all age-related 
modification (pathological and physiological) 242,243. 
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Figure 10. Holobiont and metaorganism are terms coined within the framework of ecology, evolution and 
zoology. The genetic of holobionts is highly dynamic, as well as the interactions between the three genetics, 
i.e. the nuclear DNA (indicated in the figure as “host genome”), the mitochondrial genome and the 
microbiomes. These interactions are the results of evolutionary dynamics, and co-evolved (red asterisk and 
green line) to adapt to past environment or as a consequence of migration processes. Co-evolution is a 
complex process; some variants may affect the holobiont phenotype without a co-evolution with other 
genomes (indicated with asterisks with different colors). The temporal dimension of these interactions is 
reported (bottom). Somatic mutations may arise in the genomes during lifespan (from birth to death) in a 
tissue-specific way. Thus, with aging the phenotype of the holobiont is the result of a high number of 
interactions, some of them tissue-specific. 
5.1 mtDNA in longevity and its nuclear co-evolution 
 
Mitochondria are the result of an ancient symbiotic event where a bacterium specialized in energy 
transformation has been integrated in a eukaryotic cell. As remnants of such event mitochondria have  
their own circular genome. In each mitochondria several copies of a small (16,569 base pairs) genome 
(mtDNA) is present. mtDNA contains genes involved in the functions  of mitochondria, even if the vast 
majority of the genes necessary for mitochondria physiological operations are sparse in the nuclear 
autosomal chromosomes. This dislocation of information generates epistatic effects that are responsible 
for different mitochondrial and energy phenotypes that are supposed to be important also for the aging 
process 244.  
mtDNA has been correlated to longevity in different studies. The first studies investigated the association 
between haplogroup classification and longevity. Using this approach the haplogroup J has been associated 
to longevity in Europe, Near East, Northern Italy, Ireland and Finland 245–247. Functional studies showed that 
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mtDNA molecules belonging to haplogroup J produce less ATP and ROS 248, and these associations seems to 
be population specific. In Japanese centenarians, the haplogroup D (characterized by variations in the 
complex I, such as haplogroup J) is at high frequency 249,250. However, these associations seem to be highly 
population-specific, and this could be the cause of the absence of association described in many studies 251–
253. New approach integrating genome-wide data on autosomic DNA to identify admixture events may help 
in the interpretation of mtDNA variability in centenarians.  However, the studies on haplogroups are only 
part of the possible role of mtDNA in longevity. For this reason mtDNA studies started to focus not only on 
the analysis of haplogroups but on the whole mtDNA sequence. The above-mentioned GEHA study  
analyzed 2200 nonagenarians belonging to 90+ sibpairs and the same number of younger controls, and of 
these samples 650 ultra-nonagenarians (and an equal number of controls) were completely sequenced. The 
study revealed that mutations in subunits of the OXPHOS (Oxidative phosphorylation) complex I had a 
beneficial effect on longevity, while the simultaneous presence of mutations in complex I and III (which also 
occurs in J subhaplogroups involved in LHON) and in complex I and V seemed to be detrimental. The 
authors also showed differences among the different populations and suggested that, owing to since the 
very small effect of these mutations a larger sample size is likely needed to identify more significant 
associations 254 . One interesting study regarding mitonuclear interaction focused on TOMM complex 255.  
rs2075650 located in TOMM40 was found to be associated to longevity 123, likely affecting the relative 
configuration of the partners of TOMM complex, resulting in a more efficient clearance of damaged 
mitochondria. Mitonuclear interactions between HV haplogroup of mtDNA and nuclear DNA have been 
observed associated to susceptibility to T2D in Ashkenazi Jews, indicating also a potential relation with age-
related diseases 256.   
5.2. Gut microbiota in longevity and its nuclear co-evolution 
 
In the last decades the numbers of study on gut microbiota increased exponentially owing to the possibility 
to influence its composition following external intervention. Gut microbiota plays an important role in 
human health and diseases, including age-related diseases such as CVD 257.  
5.2.1 Microbiotas within an evolutionary perspective 
The gut microbiota is a sophisticated ecosystem sensible to environmental stimuli, host genetics and 
physiological state (e.g. diet, age, among others), in which the different species are in a flux of continuous, 
ecological reshaping. It is now widely accepted that it is necessary to apply models derived from theoretical 
ecology to understand and predict microbiota dynamics 258,259. An interesting view regarding the host- 
microbiotas coevolution come from a perspective by Foster et al 260. In this paper the authors started from 
the idea that the far-reaching holobiont concept (Figure 10), might be misleading if applied simplistically to 
the host-microbiota coevolution analysis. The authors suggest that the holobiont concept bias the 
evolutionary thinking toward a simplified conceptualization where host and microbiotas would act in view 
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of common interests. To obtain effective evolutionary models the authors proposed that host and each 
microbial species has to be considered as an independent evolutionary object that reacts and evolves 
according to a Darwinian dynamics, thus undergoing potentially divergent selective pressures. This 
perspective introduces evolutionary tension in the holobiont system that can be useful to understand the 
capability of the microbiota ecosystem to respond to a variety of stimuli. A major issue in the study of host-
microbiotas coevolution in humans is related to the profound changes introduced in the last century with 
the sanitation of the anthropological environment. According to the “hygiene hypothesis” the new “clean” 
and rather sterilized human microenvironment, together with the introduction of antibiotics, caesarean 
delivery and changes in nutritional habits, involved a drastic reduction of microbiota’s diversity 261 . Such 
changes are likely too recent to allow the host genetics to adapt, thus leading to a sort of mismatch, likely 
representing a common source of dysbiosis, with far reaching consequences for aging, age-related diseases 
and longevity. Among the microbiotas of the human body the one present in the gut (gut microbiota, GM) 
is the largest and more complex, as well as the one that has been more thoroughly studied. GM plays a 
pivotal role in host metabolism homeostasis and immune system maturation, functioning, renewal and 
stability. Altered GM composition has been found in several pathological conditions such as obesity, T2D 
and autism, among others 262. In a milestone study from Xie H et al. 263, the authors analysed the GM 
composition of 250 monozygotic and dizygotic twin pairs and showed that host genetic background actively 
influences GM ecosystem. The authors also reported that with age the GM concordance tend to decrease 
within couples. Overall, it emerged that a significant portion of the phylotypes associated to diseases are 
not under genetic control, but are environmentally-determined, indicating that clinical interventions to 
restore the physiological GM ecology are likely not impaired by host genetic background. 
 
5.2.2 GM and aging 
There is a wide consensus on the fact that a lower GM biodiversity is observed during aging together with a 
concomitant increase of pro-inflammatory bacteria called “pathobionts” that usually are present at low 
concentration in healthy individuals 264. However, population-specific dynamics shape this process and for 
example the study of Biagi and colleagues 264 demonstrated that the Bacteroidetes proportion remained 
unchanged in elderly Italians, whereas Bacteroidetes proportion strikingly increased during aging 
considering Irish people 265. Extreme longevity has been characterized in term of gut microbiota, and loss of 
genes for short chain fatty acid production (considered anti-inflammatory GM metabolites) was observed. 
Recently Biagi et al., provided for the first time the phylogenetic microbiota analysis of semi-
supercentenarians, in comparison to adults, elderly, and centenarians, thus reconstructing the longest 
available human microbiota trajectory along aging266. A continuous remodelling of GM lifelong emerged, 
and GM of centenarians and semi-supercentenarians showed changes that accommodate opportunistic 
and allochthonous bacteria as well as an enrichment and/or higher prevalence of health-associated groups 
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(e.g., Akkermansia, Bifidobacterium, and Christensenellaceae)266. It is interesting to note that 
Christensenellaceae are among the most heritable  microbes 267 . As reviewed by Goodrich et al. 267, the 
heritability of gut microbiotas revealed a subset of microbes whose abundances are partly genetically 
determined by the host, but the identification of human genetic variants associated with microbiota 
composition has proven challenging, but the study of the interactions among nuclear genotype, 
environment, and the microbiotas is urgently needed owing to its capability to identify possible new 
contributors to healthy aging, longevity and its genetics, as also suggested by the evolutionary biology field. 
Microbiota in fact is at the intersection between metabolic, immunological and neuronal processes as 
recently described 268,269. Interestingly, this interkingdom communication is supported by the fact that 
genes involved in innate and adaptive immunity shape the gut microbial community. It has been 
demonstrated that the different classes of dietary lipids (experiments in mice fed lard and mice fed fish oil) 
affect the GM composition that, in turn, contributes to white adipose tissue (WAT) inflammation, insulin 
sensitivity and Toll-like receptor (TLR) activation.  These interactions between gut microbiota and saturated 
lipids promotes WAT inflammation and it is independent of adiposity 270. Moreover, the interaction 
between nuclear DNA and gut microbiota is also evident in a study on C. elegans daf-2 mutants that live 
longer due to a slower rate of aging (leading to extension of healthspan) and due to an increased ability to 
resist death due to bacterial colonization (leading to extension of decrepitude) 271. 
 
6. PERSPECTIVES  
6.1. Genome editing in aging research 
A major contribution to evaluate the effect of specific putative longevity genetic variants is provided by the 
recent development of genome editing techniques based on the molecular machineries constituted by zinc 
finger nuclease (ZFN), transcription activator-like effector nuclease (TALEN) and clustered regulatory 
interspaced short palindromic repeat (CRISPR)/Cas9-based RNA-guided DNA endonuclease. Such 
techniques allow printing with high precision specific mutations in animal and in vitro pre-clinical models to 
test the effect of genetic variants in iso-genic cells or organisms. The in depth description of such protocols 
and techniques is out of the scope of the present paper and a broad and detailed description of both 
genome and epigenome editing opportunities can be found in Keung et al., Gaj et al and Suh et al 272–274. 
Here we like to stress some aspects: i) such techniques will allow to assess the biological effect of rare 
mutations and of epistatic effects of combined genetic variants;  ii) even more interesting could be the 
combined analysis of genetic and epigenetic genome editing. A combined approach of these two 
techniques could provide innovative information on: a) allele timing, b) neutralizing or modifying effects of 
epigenetic modification; c) organ- and tissue-specific epigenetic aging rate effects on the phenotypic 
expression of candidate mutations. 
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6.2. Inclusion of environmental, social and cultural variable in the study of the genetics of longevity 
Culture normally evolves more rapidly than genes, creating novel environments that expose genes to new 
selective pressures or amplify the pre-existing ones. Counteractive niche construction may help also to 
explain the difficulties of genetics studies to identify large portions of the genetic basis of common, 
complex traits in humans. Population genetics models and anthropologists demonstrated that cultural 
processes profoundly shape human evolution, and that the genetic background records all the major 
cultural changes occurred during human evolution (i.e. milk usage, domestication of plants, agriculture, 
changing climates, social intelligence, language, cooking etc.). Cultural practices modified the 
environmental conditions that in turn led to changes in allele frequencies, as demonstrated by recent 
acceleration observed in mutation accumulation of certain regions, and some traits have an high level of 
correlation with cultural history rather than ecology.  Thus, an ecological approach of the study of the 
genetics of human longevity needs to incorporate  an integrated view of possible cultural selective pressure 
275. This process is challenging because two main issues exist in the field: 1) there are still analytical 
challenges in scanning for selection on genetic data; 2) lack of the interdisciplinary expertise that makes 
possible to integrate cultural data in the genetic analysis. Especially in observational study it is almost 
impossible to collect accurate data on the past. The use of new omics such as epigenetics may represent a 
molecular mechanism to recode important information on environmental pressure of external and internal 
environment.  
6.3. The use of biological age phenotype in the genetics of longevity 
 
Recently biomarkers of biological versus chronological age have been identified 276–278 and an increasing 
number of investigations showed that such tools are effectively capable to catch the aging rate at the 
individual level, which in turn correlates with relevant health parameters in the elderly. These studies show 
that people who are or will be affected in coming years by age-related diseases tend to present a DNA 
methylation signature of accelerated aging, and studies on human model of accelerated aging such as 
Down’s Syndrome persons showed a clear signature of accelerated aging in circulating cells and in brain 
31,279. Conversely, when these markers were applied to centenarians and their offspring a signature of 
decelerated aging emerged 280,281. Besides whole genome DNA methylation changes, among the  most 
promising markers of biological age we like to mention, N-glycans profiling 282–285 as well as markers derived 
from biochemical and anthropometric measurements such as hand grip, chair stand and lung capacity 286. 
Particularly promising for the assessment of biological age in individuals is the combination the above-
mentioned markers, possibly with the integration of classical biochemical and haematological markers 
(HDL, LDL, TG, glucose, insulin, albumin, urea, number of leukocytes, presence of anemia, among others) 
and longitudinal medical data (drugs assumption, hospitalizations). Within this frame it is of particular 
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interest the growing idea to generate a pro-inflammatory biological age marker capable to assess the 
inflammaging status of elderly subjects 287. 
Thus, biological age represents an innovative phenotypic character that should be integrated in the study of 
the genetic of longevity and of age-related diseases. In particular, biological age should complement 
chronological age data in the control cohorts, which will become progressively more heterogeneous in 
terms of health status with increasing age. In other words, the concept of healthy control becomes blurred 
with age and likely misleading, and biological age will integrate the rate of age phenotype that is known to 
be accelerated in age-related diseases and decelerated in longevity. Moreover the identification of genetic 
variants linked to accelerated/decelerated aging may be crucial to translate the results of study on extreme 
longevity in the general population. 
 
6.4. Interventions 
 
Many studies on pharmacological interventions have been performed in animal models to extend/improve 
lifespan but the possible role exerted by the genetic background has been relatively neglected. Until now 
the only intervention that is spreading also in humans is calorie restriction. Data from animal models 
(invertebrates and rodents) demonstrated that both chronic dietary restriction (DR) and genetic mutations 
in nutrient and growth signaling pathways can extend longevity by 30–50% and reduce many age-related 
diseases including CVD 288. A meeting held in 2013 289 contributed by the major experts in the field 
supported the idea that a strategy to translate these results to humans is to intervene with drugs targeting 
nutrient-response pathways and mimicking the effects of DR, that are more practical, realistic, and safe 
than drastic dietary interventions. The most promising strategies taken into account were the following: 
pharmacological inhibition of the GH/IGF-1 axis, protein restriction and Fasting Mimicking Diets, 
pharmacological inhibition of the TOR -S6K pathway, pharmacological regulation of certain sirtuin proteins 
and the use of spermidine and other epigenetic modulators, pharmacological inhibition of inflammation 
and chronic metformin use. More details are reviewed by Longo and colleagues 289.  We surmise that it is 
urgent to set up studies capable of assessing the role that the three genetics  (nuclear, mitochondrial and 
GM) can play regarding responsiveness to these and other intervention strategies at the individual level.     
7. Conclusions  
 
An innovative road map in the field of the genetics of longevity has been described in this review through 
the lens of ecological and evolutionary dynamics in order to better understand the individual aging 
trajectories assumed as highly context-dependent. First of all, a reappraisal of the definition of longevity, 
based on stringent demographic criteria and potentially applicable to all populations, and of the definition 
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of the control group was pursued. The genetics of human longevity has been presented on the basis of 
strong evidence that both human body and environment are not static, but underwent in the past and still 
undergo a complex reciprocal remodelling 2. Such dynamics has a strong impact on aging rate and quality 
and length of life (longevity). The available literature on the genetics of human longevity has been critically 
scrutinized assuming that all factors contributing to the individual’s ecological space - such as sex, individual 
(immuno) biography, family, population ancestry, social structure,  economic status and education) need to 
be taken into account as major variables for disentangling the complex GxE interactions responsible for 
aging and longevity in humans. Within this framework, the strength and limitations of the most powerful 
tools used in the genetics of longevity, such as GWAS and whole-genome sequencing - have been 
discussed, paying particular attention to genes and regions emerged from such studies, such as APOE, 
FOXO3, IL-6, IGF-1, Chromosome 9p21 and their role in CVD. Moreover, available data on the interactions 
between the three genetics of human body (nuclear, mitochondrial and GM) have been reviewed, taking 
into account the recent data on the fundamental role of the mitochondria and the emerging pervasive role 
of microbiotas - and particularly of GM in the aging process.. We surmise that such a global approach 
should also include somatic mutations that occur lifelong in the above-mentioned genomes, thus creating 
always new interactions. In conclusion, we support that the integration of the above-mentioned data are 
crucial, and that evolutionary and ecological considerations should guide this process for a better 
understanding of the genetics of longevity, particularly in humans. This approach should also contribute to 
a better  integration of the data collected in different research fields (such as epidemiology, genetics, 
anthropology  sociology, environmental studies among others) as supported by recent and relevant papers 
in the field of evolutionary medicine published in Lancet in 2017 290–292. 
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TABLES 
Table 1. GWAS on longevity and aging. PUBMED ID, name of the first author, year of publication, journal, 
type of trait analyzed, number of sample and population and platform is reported. 
PUBMED 
ID 
FIRST AUTHOR DATE JOURNAL STUDY 
DISEASE/ 
TRAIT 
INITIAL SAMPLE SIZE 
PLATFORM 
 
NA Yi Zeng 2018 JAMA 
Sex Differences in 
Genetic 
Associations with 
Longevity 
Longevity 
Han Chinese 564/1,614 
male/female 
centenarians and 
773/1,526 
80 male/female middle-
aged controls. 
5.6 million SNPs 
(900,015 
genotyped SNPs 
and 4.8 million 
imputed SNPs) 
(Illumina 
HumanOmniZho
ngHua-8 
BeadChips) 
 
29227965 Pilling 2017 Aging US 
Human longevity: 
25 genetic loci 
associated in 
389,166 UK 
biobank 
participants 
Parental 
longevity 
[mother’s age 
≥90 years, 
father’s ≥87 
years),] 
UK Biobank: 451,447 
participants 
Health and Retirement 
Study (HRS): 15,708 
Wisconsin Longitudinal 
Study (WLS): 9012 
Illumina, 
Affymetrix, 
Imputation of 
39,235,157 
genetic variants 
29030599 Joshi PK 2017 
Nat 
Commun 
Genome-wide 
meta-analysis 
associates HLA-
DQA1/DRB1 and 
LPA and lifestyle 
factors with 
human longevity. 
Parental 
lifespan 
up to 586,626 European 
ancestry individuals, up to 
19,433 African ancestry 
individuals 
Affymetrix, 
Illumina [at 
least 
13,643,373] 
(imputed) 
28748955 Mc Daid 2017 
Nat 
Commun 
Bayesian 
association scan 
reveals loci 
associated with 
human lifespan 
and linked 
biomarkers 
Parental 
lifespan 
116,279 individuals in the 
UK Biobank  
27816938 Tanaka T 2017 
J Gerontol 
A Biol Sci 
Med Sci 
Genome-wide 
Association Study 
of Parental Life 
Span. 
Parental 
longevity (at 
least one long-
lived parent) 
1,140 European American 
individuals with at least 
one long-lived parent, 
3,894 European American 
individuals, 137 African 
American individuals with 
at least one long-lived 
parent, 545 African 
American individuals 
Illumina [~ 
2,500,000] 
27029810 Joshi PK 2016 
Nat 
Commun 
Variants near 
CHRNA3/5 and 
APOE have age- 
and sex-related 
effects on human 
lifespan. 
Parental 
Lifespan 
138,536 British ancestry 
mothers, 133,545 British 
ancestry fathers 
Affymetrix 
[73,355,667] 
(imputed) 
27015805 Pilling LC 2016 
Aging 
(Albany 
NY) 
Human longevity 
is influenced by 
many genetic 
variants: 
evidence from 
75,000 UK 
Biobank 
participants. 
Parental 
longevity 
(mother's age 
at death) 
52,776 middle-aged 
British individuals 
Affymetrix 
[9,658,292] 
(imputed) 
26912274 Zeng Y 2016 Sci Rep 
Novel loci and 
pathways 
significantly 
Longevity (100 
years and 
older) 
2,178 Han Chinese 
ancestry centenarian 
cases, 2,299 Han Chinese 
Illumina 
[5,595,657] 
(imputed) 
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associated with 
longevity. 
ancestry middle-age 
controls 
26677855 Fortney C 2015 Plos Gen 
Genome-Wide 
Scan Informed by 
Age-Related 
Diseases 
Identifies Loci for 
Exceptional 
Human Longevity 
Longevity 
Discovery: New England 
Centenarians study (801 
centenarians) and 914 
controls and 90PLUS 
(7330 individuals 90 or 
older and 16121 young 
controls (age 65 or less) 
Illumina 
[243,980] 
25918517 Yashin A 2015 
Front 
Genet 
Genetics of 
aging, health, 
and survival: 
dynamic 
regulation of 
human longevity 
related traits. 
Lifespan 
After applying the QC 
procedure  
1111individuals 
 
Affymetrix 
[429,783] 
25199915 Broer L 2014 
J Gerontol 
A Biol Sci 
Med Sci 
GWAS of 
Longevity in 
CHARGE 
Consortium 
Confirms APOE 
and FOXO3 
Candidacy. 
Longevity (90 
years and 
older) 
6,036 European ancestry 
cases, 3,757 European 
ancestry controls 
Affymetrix, 
Illumina 
[2,500,000] 
(imputed) 
24688116 Deelen J 2014 
Hum Mol 
Genet 
Genome-wide 
association meta-
analysis of 
human longevity 
identifies a novel 
locus conferring 
survival beyond 
90 years of age. 
Longevity (90 
years and 
older) 
5,406 European ancestry 
cases, 15,112 European 
ancestry controls 
Illumina 
[2,470,825] 
(imputed) 
23286790 Beekman M 2013 Aging Cell 
Genome-wide 
linkage analysis 
for human 
longevity: 
Genetics of 
Healthy Aging 
Study 
Longevity 
(90 years and 
older) 
2118 nonagenarian 
Caucasian sibling pairs 
Illumina 
HumanLinkage-
12 Genotyping 
BeadChip 
[6,090] 
22279548 Sebastiani P 2012 Plos One 
Genetic 
Signatures of 
Exceptional 
Longevity in 
Humans 
 
Discovery 801  
subjects enrolled in the 
New England Centenarian 
Study (NECS) 95 to 119 
years (median age 104 
years 
and 914 genetically 
matched controls.  
 
 
21782286 Walter S 2011 
Neurobiol 
Aging 
A genome-wide 
association study 
of aging. 
Aging (time to 
death) 
25,007 European ancestry 
individuals 
Affymetrix, 
Illumina [~ 
2,500,000] 
(imputed) 
21740922 Nebel A 2011 
Mech 
Ageing Dev 
A genome-wide 
association study 
confirms APOE as 
the major gene 
influencing 
survival in long-
lived individuals. 
Longevity 
763 European ancestry 
individuals (mean 
age=99,7), 1,058 
European ancestry 
individuals (mean age 
60,2 years) 
Affymetrix 
[664,472] 
21612516 Malovini A 2011 
Rejuvenati
on Res 
Association study 
on long-living 
individuals from 
Southern Italy 
identifies 
rs10491334 in 
Longevity 
Southern Italy 
582 individuals (age range 
90–109 
years) and 784 young 
control individuals (age 
range 18–45 
Illumina 
[298,715] 
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the CAMKIV gene 
that regulates 
survival proteins. 
years)  
20834067 Yashin AI 2010 
Aging 
(Albany 
NY) 
Joint influence of 
small-effect 
genetic variants 
on human 
longevity. 
Longevity 
1,173 individuals 
(Framingham Heart 
Study) 
NR [~ 550,000] 
20304771 Newman AB 2010 
J Gerontol 
A Biol Sci 
Med Sci 
A meta-analysis 
of four genome-
wide association 
studies of 
survival to age 90 
years or older: 
the Cohorts for 
Heart and Aging 
Research in 
Genomic 
Epidemiology 
Consortium. 
Longevity 
1,836 European ancestry 
long-lived individuals 
(survival to age 90 years 
or older), 1,955 European 
ancestry controls (range 
55-80 years) 
Affymetrix, 
Illumina 
[2,287,520] 
(imputed) 
17903295 Lunetta KL 2007 
BMC Med 
Genet 
Genetic 
correlates of 
longevity and 
selected age-
related 
phenotypes: a 
genome-wide 
association study 
in the 
Framingham 
Study. 
Aging (age at 
death) 
1,345 individuals from 
330 families (Framingham 
Heart Study) 
Affymetrix 
[70,897] 
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Table 2.  Overview of the genetics of human longevity. The first column reports the data obtained from the 
published studies and the second column describes possible guidelines for future researches.  
Lessons from the past Guidelines for the future 
THE PROPER DEFINITION OF PHENOTYPES TO INCLUDE IN GENETICS STUDIES 
 
1. Longevity is defined according to demographic 
criteria (one percentile survival) 
2. Controls can include healthy individuals, familial 
members and also individuals with age-related 
diseases as a paradigm of accelerated aging 
3. Longevity is different between males and females 
 
 
1. Avoid definition of longevity on the basis of self 
reported data 
2. Biological age need to be included in the definition of 
controls 
3. Genetics analysis need to performed separately for 
male and females when sample size is high enough 
THE ECOLOGICAL PERSPECTIVE 
 
1. (Immuno)biography and somatic mutations are 
dynamic processes that change during aging 
2. The familial history shapes (directly or indirectly) 
different gene-environment interactions  
3. Geography, cultural aspect, birth cohort and socio-
economic dynamics change gene-environment 
interactions 
4. Evolutionary dynamics (migration and natural 
selection) shape the genetic background of different 
populations (such as APOE) -->  the genetic of 
longevity is population specific 
 
1. The genetic of longevity is not a static concept and a 
protective/risk allele need to be integrated with other 
data that characterized the individual in a given time 
2. Identify statistical model to evaluate the direct effect 
of inherited variants but also the indirect effect of 
variants carried by parents 
3. Define risk/protective allele according to the birth 
cohort, geography and socio-economic status  
4. An evolutionary medicine and the study of genetic 
structure of each population will help in identifying 
population specific genes and pathways correlated 
with longevity  
STATE OF THE ART 
 
1. Variants involved in age-related diseases were 
identified in many GWAS/gene candidate studies of 
longevity (such as APOE, chr9p21) 
2. Genetic risk factors are age-specific and play a major 
role in the process of remodeling 
3. GWAS highlighted that common and population 
specific genes involved in longevity. 
4. Longevity depends on small-effect alleles (and 
association signals tend to be spread across most of 
the genome).The GWAS threshold of 10-8 may not be 
valid for longevity. 
5. Gene candidate studies showed the role many genes 
involved in longevity: APOE/TOMM40, chr9p21, 
chr15q33.3 FOXO, IGF1, IL6, SIRTUINS among others 
 
1. Patients with age-related diseases have to be 
included in the study of human longevity (following 
the geroscience perspective) and centenarians need 
to be included in the study of age-related diseases as 
a group of super-control 
2. Complex allele timing and antagonistic pleiotropy 
dynamics help in identifying the role of the genetic 
variants in different environment 
3. To perform study where centenarians and controls 
are homogeneous in term of population genetic 
structure  
4. Include new methods of analysis such as pathway 
analysis or as suggested by Boyle and colleague using 
an "omnigenic approach" mapping cell-specific 
regulatory networks. 
5. Evaluate the effect of these genes by genome editing 
 
 
HUMAN IS A METAORGANISM 
 
1. Host genome interacts and coevolved with mtDNA 
2. Host genome interacts and coevolved with gut 
microbiota 
 
 
1. Characterize mtDNA variability and heteroplasmy and 
the nuclear-mitocondria interactions 
2. Focus on the interaction between the "three 
genetics" (host, mtDNA, microbiome) usually 
considered separately 
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Table 3. The complexity of APOE gene variants 
 
MACRO AND MICRO-EVOLUTIONARY BACKGROUND 
 APOE-e4 is the ancestral allele typical of modern humans; 
 APOE-e2 and APOE-e3 evolved around 200,000-300,000 years ago; 
 APOE-e4 is associated with improved cognitive function in Amazonian forager-horticulturalists 
with a high parasite burden; 
 High frequency of APOE-e4 was maintained in the population because it confers a beneficial effect 
during infections and in the environment where pathogens were more prevalent and the first 
cause of mortality (data on a rural Ghanaian population); 
TODAY GEOGRAPHIC DISTRIBUTION 
 APOE-4 showed a cline in Europe (from 20% in North Europe to 6/7% in Southern Europe) 
 e4 allele in human populations follows a sort of U-shaped latitudinal trajectory --> high 
frequencies (up to approximately 40–50% of the population) in equatorial and high latitudes and 
low frequencies in middle latitudes 
INVOLVEMENT IN PHYSIOLOGICAL TRAITS 
 Lipid metabolism, regulating production, conversion  
 APOE-e4 is associate to high cholesterol  
 clearance of lipoproteins  
 it is expressed in different tissues, macrophage, adipose tissue, nervous system and liver 
 APOE-e4 allele had significantly higher levels of mean luteal progesterone than women with 
genotypes without ApoE4, which indicates higher potential fertility 
 In mice APOE-4 carriers are more vulnerable to a dietary deficiency in omega-3 fatty acids and 
cognitive decline 
 High levels of physical activity reduce disease risks in ɛ4 carriers 
 Spatial memory of transgenic mice carrying human forms of these proteins and find that it is 
impaired in mice with apoE4 but not those with apoE3 
INVOLVEMENT IN PATHOLOGICAL TRAITS 
 APOE-e4 is associated to Alzheimer's disease (AD) and cardiovascular diseases (APOE-e4) 
 People with APOE-e3 o APOE-e2 have later AD onset than APOE-e4 
LONGEVITY 
 APOE-e4 is negatively associated to longevity in many studies and meta-analysis on human 
longevity.  
 The gene variants identified in these regions are located also in TOMM40 and APOC1.  
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